| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 1.92e-05 | 379 | 19 | 5 | GO:0045229 | |
| Domain | Tscrpt_rep_NocA-like | 9.80e-07 | 2 | 19 | 2 | IPR022129 | |
| Domain | nlz1 | 9.80e-07 | 2 | 19 | 2 | PF12402 | |
| Domain | - | 4.34e-03 | 679 | 19 | 4 | 3.30.160.60 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 4.69e-03 | 694 | 19 | 4 | IPR013087 | |
| Domain | ZINC_FINGER_C2H2_2 | 6.93e-03 | 775 | 19 | 4 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 6.99e-03 | 777 | 19 | 4 | PS00028 | |
| Domain | Znf_C2H2-like | 7.61e-03 | 796 | 19 | 4 | IPR015880 | |
| Domain | Znf_C2H2 | 7.91e-03 | 805 | 19 | 4 | IPR007087 | |
| Domain | ZnF_C2H2 | 8.01e-03 | 808 | 19 | 4 | SM00355 | |
| Pubmed | 'Nude', a new hairless gene with pleiotropic effects in the mouse. | 2.83e-07 | 2 | 19 | 2 | 5980117 | |
| Pubmed | Rapid chromatin repression by Aire provides precise control of immune tolerance. | 8.48e-07 | 3 | 19 | 2 | 29335648 | |
| Pubmed | 8.48e-07 | 3 | 19 | 2 | 19487464 | ||
| Pubmed | 1.70e-06 | 4 | 19 | 2 | 27075243 | ||
| Pubmed | Targeting Tyro3 ameliorates a model of PGRN-mutant FTLD-TDP via tau-mediated synaptic pathology. | 1.70e-06 | 4 | 19 | 2 | 29382817 | |
| Pubmed | Hoxa2 selectively enhances Meis binding to change a branchial arch ground state. | 2.82e-06 | 5 | 19 | 2 | 25640223 | |
| Pubmed | Genes specifically expressed at growth arrest of mammalian cells. | 2.82e-06 | 5 | 19 | 2 | 3409319 | |
| Pubmed | Early molecular events during retinoic acid induced differentiation of neuromesodermal progenitors. | 1.86e-05 | 12 | 19 | 2 | 27793834 | |
| Pubmed | 2.20e-05 | 13 | 19 | 2 | 35075189 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 3.51e-05 | 351 | 19 | 4 | 38297188 | |
| Pubmed | The transcription factor Zfp503 promotes the D1 MSN identity and represses the D2 MSN identity. | 3.83e-05 | 17 | 19 | 2 | 36081908 | |
| Pubmed | Localization of growth arrest-specific genes on mouse chromosomes 1, 7, 8, 11, 13, and 16. | 5.90e-05 | 21 | 19 | 2 | 1347472 | |
| Pubmed | 7.10e-05 | 23 | 19 | 2 | 25636444 | ||
| Pubmed | 8.42e-05 | 25 | 19 | 2 | 27471260 | ||
| Pubmed | 9.10e-05 | 162 | 19 | 3 | 25796446 | ||
| Pubmed | Dlx1/2-dependent expression of Meis2 promotes neuronal fate determination in the mammalian striatum. | 1.39e-04 | 32 | 19 | 2 | 35156680 | |
| Pubmed | Activation of beta-catenin signaling programs embryonic epidermis to hair follicle fate. | 1.48e-04 | 33 | 19 | 2 | 18480165 | |
| Pubmed | Palmitoylation regulates epidermal homeostasis and hair follicle differentiation. | 1.57e-04 | 34 | 19 | 2 | 19956733 | |
| Pubmed | 1.86e-04 | 37 | 19 | 2 | 25742799 | ||
| Pubmed | Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. | 2.76e-04 | 45 | 19 | 2 | 21378990 | |
| Pubmed | 3.14e-04 | 48 | 19 | 2 | 24262325 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 3.19e-04 | 248 | 19 | 3 | 24006456 | |
| Pubmed | 4.28e-04 | 56 | 19 | 2 | 34170322 | ||
| Pubmed | 4.91e-04 | 60 | 19 | 2 | 35175194 | ||
| Pubmed | Genome-wide CRISPR screening reveals genetic modifiers of mutant EGFR dependence in human NSCLC. | 5.19e-04 | 293 | 19 | 3 | 31741433 | |
| Interaction | HOXA1 interactions | 1.59e-05 | 356 | 19 | 5 | int:HOXA1 | |
| ToppCell | mild-Myeloid-mDC|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.00e-06 | 184 | 19 | 4 | 8b37c00d59d9992d3b43268991da7bb94646c70e | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.23e-06 | 194 | 19 | 4 | b16ed97eb6b7b7a220e943474c0d85c141b6e3a5 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.23e-06 | 194 | 19 | 4 | 2210f0755882d8f04edb4c109fb17c3f9149f6f7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.26e-06 | 195 | 19 | 4 | 4cbc36fb3ef9aef61367d3b37070a9a85fae1418 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.29e-06 | 196 | 19 | 4 | 553c22c7d48f3b4f6f2b2f10d6e668c5ebb09e8c | |
| ToppCell | PBMC-Control-Myeloid-cDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.29e-06 | 196 | 19 | 4 | e1f763fa9c11bf5f4d80e79f70f9485724ac23fe | |
| ToppCell | PBMC-Control-Myeloid-cDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.29e-06 | 196 | 19 | 4 | d376168e15ec1cf618723259966c76be3698b9b0 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.29e-06 | 196 | 19 | 4 | 4a9095ba3f6709f88f32bf09184553f4bd211f43 | |
| ToppCell | PBMC-Severe-Myeloid-cDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.31e-06 | 197 | 19 | 4 | 22e4ffb5de483eaf78f14badf3d08db898e3b3dd | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.31e-06 | 197 | 19 | 4 | 9162ede5572326c00ede0769fe7f4e0dd14d2340 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.31e-06 | 197 | 19 | 4 | 0460b6907743a354792b5bc40bff01aac7c41684 | |
| ToppCell | PBMC-Severe-Myeloid-cDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.31e-06 | 197 | 19 | 4 | 346974c6c5809a3fe88cbf067e2d64c340310a31 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.31e-06 | 197 | 19 | 4 | 89fe4885efc8db142c0dc0506840ae8aceba9ef9 | |
| ToppCell | Healthy_donor-cDC|Healthy_donor / disease group, cell group and cell class (v2) | 1.31e-06 | 197 | 19 | 4 | b57a27e5b855bbdd1dfa352540599d260dc482aa | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.31e-06 | 197 | 19 | 4 | 1ae45c1ec3b3f88e0c1f99de58c58b1ec1b968ee | |
| ToppCell | PBMC-Mild-Myeloid-cDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.31e-06 | 197 | 19 | 4 | 021c9c48375259b808e1f36a029c4fe6971c00eb | |
| ToppCell | PBMC-Mild-Myeloid-cDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.31e-06 | 197 | 19 | 4 | 18df0e447bcea2a405a357563f87bacc57466227 | |
| ToppCell | Healthy/Control-cDC|Healthy/Control / Disease group and Cell class | 1.31e-06 | 197 | 19 | 4 | 926423aae9fcf654f84b0f7621103a6a22d3aced | |
| ToppCell | mild_COVID-19-cDC|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.31e-06 | 197 | 19 | 4 | 44ebd3f967779bb7753fc6dcd9fde6d682f9ccd6 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-06 | 197 | 19 | 4 | 236a40eb6c08e1d179cf0fb5450b032975c5f6b6 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.31e-06 | 197 | 19 | 4 | f78f44dcd7855c96f148678c1f416075aef71b4e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.34e-06 | 198 | 19 | 4 | 898ef4f02443780f9b1fc08b73a165fda0ca5cde | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.34e-06 | 198 | 19 | 4 | d0371e2ca9e25727b35985940f6228f9d8e49727 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.34e-06 | 198 | 19 | 4 | 08ad0bece508bb4f9cc126d94839b5c89ce21ba8 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-conventional_dendritic_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.34e-06 | 198 | 19 | 4 | 42be18aef4f656a86c61630b061826a858c496fd | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-cDC|COVID-19_Mild / Disease, condition lineage and cell class | 1.39e-06 | 200 | 19 | 4 | b8f52e65813d331c49cdd5f354fdfec6fc8c339e | |
| ToppCell | Control-Control-Myeloid-cDC|Control / Disease, condition lineage and cell class | 1.39e-06 | 200 | 19 | 4 | 1375d199320feb85ba06e74b10df6521e790addf | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-cDC|COVID-19_Severe / Disease, condition lineage and cell class | 1.39e-06 | 200 | 19 | 4 | e7b808d8ed65343a4345fafb03015fe4f7ce302f | |
| ToppCell | mild-cDC|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.39e-06 | 200 | 19 | 4 | d6409ee5b9067be3dd2f852825e09151b5b22d7c | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Enterocyte_(Proximal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-05 | 159 | 19 | 3 | 709b57f992a29878cc899d760d144d36cb5cb280 | |
| ToppCell | NS-critical-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.10e-05 | 160 | 19 | 3 | c61869d9dbba250270e59366e15af204e5b4395d | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-DC1|bone_marrow / Manually curated celltypes from each tissue | 4.18e-05 | 161 | 19 | 3 | 2f068ee643de2f647c289779a6624265ab9a749b | |
| ToppCell | critical-Myeloid-Mast_cell|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.49e-05 | 165 | 19 | 3 | 34a1cc6ccd46c059354e8fbde1ac69f202695a4e | |
| ToppCell | NS-critical-d_07-13-Myeloid-Mast_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.66e-05 | 167 | 19 | 3 | 8a14fd980d8ebe8ef0216221f619d31aaa27ff15 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.83e-05 | 169 | 19 | 3 | a0681317867e31319210a23e56660a53f4529efe | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.91e-05 | 170 | 19 | 3 | 7bba77ae34a0259fad6ee98cf665ff50f77a1328 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.91e-05 | 170 | 19 | 3 | a43b977a7fe745536cf96b7c080397d9fa73086b | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma-monocytoid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.09e-05 | 172 | 19 | 3 | 9befd44bce43eb5dc1fe3d2e44608f442cf74a47 | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.09e-05 | 172 | 19 | 3 | c41f5a66781bbf63afce7ca5d118cc6d8e0fe0bc | |
| ToppCell | Immune_cells-pro-B|World / Lineage and Cell class | 5.26e-05 | 174 | 19 | 3 | e173adbf5789dfa20f3cbc668efde5f0992ac219 | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Control / Condition, Lineage and Cell class | 5.26e-05 | 174 | 19 | 3 | 4c64ff5666812fb4efa440ba4faeca51d916d68e | |
| ToppCell | moderate-Myeloid-Mast_cell|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.35e-05 | 175 | 19 | 3 | bbd2971bc6d69e507f90a637834d0936c205c590 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.35e-05 | 175 | 19 | 3 | c58a1f02d1e559d3638fe1500e960e82a8a7187b | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-DC2|lymph-node_spleen / Manually curated celltypes from each tissue | 5.45e-05 | 176 | 19 | 3 | 72a3bbab0540ae3e3c94b9573cdb9298a024dbc4 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.63e-05 | 178 | 19 | 3 | 5289ac61637224ae70ffbc2d164d73116f10af40 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.63e-05 | 178 | 19 | 3 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.63e-05 | 178 | 19 | 3 | 8151e5d73407fd9cba382b69a2bc707c81790c7f | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.63e-05 | 178 | 19 | 3 | c85de851b39cb8ef7ea1866ab64c6a387788273a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.73e-05 | 179 | 19 | 3 | ba64bfb757d6e3be631ee95abfa24b47861f6a14 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_33|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.73e-05 | 179 | 19 | 3 | 13d80ae2e43a5daad0aeb5f47338efca2c58800a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.73e-05 | 179 | 19 | 3 | 8bd85ee92791996377bcafed198c1bb3c9af4c3c | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.73e-05 | 179 | 19 | 3 | f2e8fc975c30992611630197b79daaeef7c4211d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.02e-05 | 182 | 19 | 3 | d57d18732aa6fb7b2d430601568f9ba525ac6e3c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.02e-05 | 182 | 19 | 3 | 9a68d3bd1cc9139de9e9e711c249d47ade826bb1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.02e-05 | 182 | 19 | 3 | c3fb1460160744144aa31afc76c0a4d42ebdeb91 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-DC2|bone_marrow / Manually curated celltypes from each tissue | 6.11e-05 | 183 | 19 | 3 | f482e4fe011fa450a475034b1e25587233855bdb | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.21e-05 | 184 | 19 | 3 | 5535b85b3ad3d0c0392d5884fdc2939c7e1b1c3e | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.21e-05 | 184 | 19 | 3 | 2c2125b8030af83f7a6d59a7102d4de8e0ac1988 | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC-cDC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.21e-05 | 184 | 19 | 3 | 9d678b24532b7763f2e73f7ccb496259977c5204 | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC-cDC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.21e-05 | 184 | 19 | 3 | 383374ad17bd322b8d703a22e475d34ca7b2e6b6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.31e-05 | 185 | 19 | 3 | 9438097e94219c1db922b8507e3a29106d32a923 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM4|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.31e-05 | 185 | 19 | 3 | 274b8acccdfe434d14af4cb32fb615c06ec98435 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.31e-05 | 185 | 19 | 3 | 29d7ddcb9a2e45f76cd5611f7c52b6df689effd3 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM4-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.31e-05 | 185 | 19 | 3 | b640d9ed6a1e6aa595053065bb992efc0402353e | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM4-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.31e-05 | 185 | 19 | 3 | 780bdb63ef913a09930063286011c9108381d3a9 | |
| ToppCell | 343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.31e-05 | 185 | 19 | 3 | d4ba36bdb8b7e3a62e827269484f89f790eaa5ef | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-DC2|Liver / Manually curated celltypes from each tissue | 6.42e-05 | 186 | 19 | 3 | 92ef569c8f864d3abaa087cd3ce0366e8f9f50c2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.42e-05 | 186 | 19 | 3 | d6c8ce2a32c218dcc63d861cc247152430ed3c8c | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-DC2|blood / Manually curated celltypes from each tissue | 6.52e-05 | 187 | 19 | 3 | ab9c9930341527122f26fe5544c5c4818d1fd1b5 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_8|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.62e-05 | 188 | 19 | 3 | 8431991e68b8e9c5eb72212460f6da679ea3b85a | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_8|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.62e-05 | 188 | 19 | 3 | d8f10b3ad11bc99a63f44560e39791085256e5c8 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.73e-05 | 189 | 19 | 3 | c81b38cda4525254fe4fa137a4c9bc9abe0363bb | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-05 | 189 | 19 | 3 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.73e-05 | 189 | 19 | 3 | 807922b5ea0faddd3abfa9ec1b53f3f2b00e61bf | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 6.73e-05 | 189 | 19 | 3 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.94e-05 | 191 | 19 | 3 | 4b94c8b0183ae07d173646b7e7e1d9db04ec9637 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.94e-05 | 191 | 19 | 3 | 6cda82a994f4b205cf54590c979d7c9f3be2b4c8 | |
| ToppCell | (01)_Dendritic_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 6.94e-05 | 191 | 19 | 3 | 1f4c8078e1a6cd14937c714330af608caced2acf | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.94e-05 | 191 | 19 | 3 | 4257f02856f3510981e9f84d465d91448d6126e2 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.94e-05 | 191 | 19 | 3 | 2699e9bb872f2b561bb976dfdc2746e359bc9daf | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.94e-05 | 191 | 19 | 3 | 92c5a26b90a55831039220341d863cf2940f3c9b | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.05e-05 | 192 | 19 | 3 | dfb9101622f7d2f2c392e850cff07becfc8c655e | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.05e-05 | 192 | 19 | 3 | d39133cf1a20af6f2970188630fc3b27a4cfc9c5 | |
| ToppCell | BLOOD--(3)_DC_(cDC+pDC)| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.05e-05 | 192 | 19 | 3 | e290c55a1321e9e577f49e8ba20501b2c8150044 | |
| ToppCell | Control-Myeloid-MoAM4|Control / Disease group,lineage and cell class (2021.01.30) | 7.05e-05 | 192 | 19 | 3 | 1da7c303a2e36af4a9d8ec30a11380d9b1897922 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.05e-05 | 192 | 19 | 3 | 6184163dbfca882824cb266bb9030d9f79e3acb0 | |
| ToppCell | control-Myeloid-mDC|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.16e-05 | 193 | 19 | 3 | 5e43024763932a679c33d83cf8f606612bc0f600 | |
| ToppCell | VE-pDC-|VE / Condition, Cell_class and T cell subcluster | 7.16e-05 | 193 | 19 | 3 | 583724de588fcde3aeda056138c522dc0225a387 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.16e-05 | 193 | 19 | 3 | f492ed02a46f3a45dc6005f9f18ab12a84bfa2a3 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.16e-05 | 193 | 19 | 3 | 1f978e102a029a6beb10913052cd0a20c7253e8e | |
| ToppCell | VE-pDC|VE / Condition, Cell_class and T cell subcluster | 7.16e-05 | 193 | 19 | 3 | bb759dc9ef0ec41d655002f59021d62d62d44289 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.27e-05 | 194 | 19 | 3 | 5c60670ec24470225fabaa6071fdb4ef6e579840 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.27e-05 | 194 | 19 | 3 | 6af2971d83f5ad6aed16d0ceb8bfc52f3947bc10 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-05 | 194 | 19 | 3 | ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.27e-05 | 194 | 19 | 3 | e3688f4252aae5f849f025d7f453ff4c0c14590b | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic|lymph-node_spleen / Manually curated celltypes from each tissue | 7.27e-05 | 194 | 19 | 3 | e2d9186a7e8d1a4a71d7bd6dba7fc955d55479e6 | |
| ToppCell | normal_Lung-Epithelial_cells-AT1|normal_Lung / Location, Cell class and cell subclass | 7.38e-05 | 195 | 19 | 3 | 569d1ebc5a5aa110a2430b096755ae35354040c4 | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-conventional_dendritic_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.38e-05 | 195 | 19 | 3 | 0fcc41cda3e5f921748cf7e7fe48dd7ca1de4636 | |
| ToppCell | (010)_cDC|World / immune cells in Peripheral Blood (logTPM normalization) | 7.38e-05 | 195 | 19 | 3 | 4aabb3f5ce70100e4d98d7fa9f8d12e84fb9fe3d | |
| ToppCell | myeloid-cDC|World / Lineage and Cell class | 7.49e-05 | 196 | 19 | 3 | 60258111945ee823f325bff032049c60377206d1 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 3.41e-05 | 99 | 19 | 3 | EFO_0004611, EFO_0007878 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 3.73e-05 | 102 | 19 | 3 | EFO_0004329, EFO_0004611 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 4.80e-05 | 111 | 19 | 3 | EFO_0004530, EFO_0008595 | |
| Disease | antihyperlipidemic drug use measurement | 5.34e-05 | 115 | 19 | 3 | EFO_0803367 | |
| Disease | polyunsaturated fatty acid measurement | 7.87e-05 | 131 | 19 | 3 | EFO_0010733 | |
| Disease | stroke, coronary artery disease | 8.19e-05 | 21 | 19 | 2 | EFO_0000712, EFO_0001645 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 1.59e-04 | 166 | 19 | 3 | EFO_0004530, EFO_0004611 | |
| Disease | HMG CoA reductase inhibitor use measurement | 2.32e-04 | 189 | 19 | 3 | EFO_0009932 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 2.62e-04 | 197 | 19 | 3 | EFO_0005680 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 3.39e-04 | 215 | 19 | 3 | EFO_0008317, EFO_0008591 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 3.49e-04 | 43 | 19 | 2 | EFO_0022290 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 3.63e-04 | 220 | 19 | 3 | EFO_0004529, EFO_0008317 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 3.82e-04 | 224 | 19 | 3 | EFO_0004530, EFO_0008317 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 3.82e-04 | 224 | 19 | 3 | EFO_0004574, EFO_0008317 | |
| Disease | saturated fatty acids measurement | 3.83e-04 | 45 | 19 | 2 | EFO_0022304 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 3.87e-04 | 225 | 19 | 3 | EFO_0008317, EFO_0010351 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 4.08e-04 | 229 | 19 | 3 | EFO_0004639, EFO_0008317 | |
| Disease | phospholipids in very small VLDL measurement | 4.92e-04 | 51 | 19 | 2 | EFO_0022300 | |
| Disease | phospholipids in medium VLDL measurement | 5.11e-04 | 52 | 19 | 2 | EFO_0022154 | |
| Disease | cholesteryl ester measurement | 5.71e-04 | 257 | 19 | 3 | EFO_0010351 | |
| Disease | very low density lipoprotein cholesterol measurement | 5.90e-04 | 260 | 19 | 3 | EFO_0008317 | |
| Disease | triglycerides in LDL measurement | 5.93e-04 | 56 | 19 | 2 | EFO_0022320 | |
| Disease | triglycerides in IDL measurement | 6.36e-04 | 58 | 19 | 2 | EFO_0022149 | |
| Disease | phospholipids in small VLDL measurement | 6.80e-04 | 60 | 19 | 2 | EFO_0022146 | |
| Disease | triglycerides in medium LDL measurement | 7.26e-04 | 62 | 19 | 2 | EFO_0022322 | |
| Disease | apolipoprotein B measurement | 7.48e-04 | 663 | 19 | 4 | EFO_0004615 | |
| Disease | coronary artery disease | 7.78e-04 | 1194 | 19 | 5 | EFO_0001645 | |
| Disease | triglycerides in small LDL measurement | 7.98e-04 | 65 | 19 | 2 | EFO_0022323 | |
| Disease | triglycerides in very small VLDL measurement | 8.72e-04 | 68 | 19 | 2 | EFO_0022144 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 8.98e-04 | 69 | 19 | 2 | EFO_0022341 | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 1.06e-03 | 75 | 19 | 2 | EFO_0022287 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 1.15e-03 | 78 | 19 | 2 | EFO_0022187 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HCSAGHSCIFTVSGT | 66 | P28799 | |
| GTSTPSFHGSHCSGS | 391 | Q9NUG4 | |
| SFHGSHCSGSDHSSL | 396 | Q9NUG4 | |
| HGNGSTCHTVSGTFE | 691 | Q9UKP4 | |
| FGHHESSSWQSSGCT | 1401 | Q86YZ3 | |
| GSFHCSCHSGFELSS | 176 | Q14393 | |
| AASGGCHSSEASSSA | 46 | A8MQT2 | |
| CPSSTEHASASANGH | 381 | P15151 | |
| SKHAGFSCSSFVSDG | 41 | O15353 | |
| HCSTGSGSASFAHTA | 1261 | P51532 | |
| SGLSHSAFSSGASSH | 256 | Q8IXZ3 | |
| HGASHLGGSSCSTCS | 386 | Q9H7S9 | |
| SFSSAASISFGCAHS | 786 | Q12816 | |
| ASISFGCAHSTSTSF | 791 | Q12816 | |
| GSQQSAHSSCHPSFA | 1631 | Q8NI35 | |
| HCASHLAGAAAASAS | 436 | Q96F45 | |
| DAHGSCLHASTANGS | 511 | Q7RTT9 | |
| SAGEHGDCTTHSTAA | 1401 | Q5JPB2 | |
| NCSTSSSGNVHHCFS | 41 | Q01453 | |
| ASLGSSAVTCHSAGS | 251 | Q9NYI0 | |
| TTSGHSEESATFHGS | 521 | Q9UKN1 |